ケンタッキー州における悪性黒色腫の臨床試験
ケンタッキー州内の拠点で、悪性黒色腫に関する21件の研究が参加者を募集しています。
ケンタッキー州内の都市
公式研究テキスト（英語）
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- CommonSpirit Saint Joseph Hospital - Bardstown, Bardstown
- Commonwealth Cancer Center-Corbin, Corbin
- Saint Elizabeth Healthcare Edgewood, Edgewood
- 他5件
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069A Study of BI 3810944 in Patients With Advanced Cancer
- University of Louisville, Louisville
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07224425A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
- Markey Cancer Center Clinical Research Organization, Lexington
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06246916Pan-tumor MRD Study
- Baptist Health Corbin, Corbin
- Baptist Health Hardin, Elizabethtown
- Baptist Health Lexington, Lexington
- 他1件
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/24更新 · NCT06605404Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
- CommonSpirit Saint Joseph Hospital - Bardstown, Bardstown
- Commonwealth Cancer Center-Corbin, Corbin
- CommonSpirit Saint Joseph Hospital - Lexington, Lexington
- 他5件
被験者募集中第3相
75歳以上 · 全性別 · 2026/09/24更新 · NCT07068074A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- Mercy Health - Paducah Medical Oncology and Hematology, Paducah
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/15更新 · NCT04511013Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
- University of Kentucky/Markey Cancer Center, Lexington
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/31更新 · NCT05896839Project: Every Child for Younger Patients With Cancer
- University of Kentucky/Markey Cancer Center, Lexington
- Norton Children's Hospital, Louisville
被験者募集中観察研究
25歳以下 · 全性別 · 2026/08/25更新 · NCT02402244Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- Norton Cancer Institute, Louisville
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/29更新 · NCT04198766Safety and Efficacy of OBX-115 in Advanced Solid Tumors
- James Graham Brown Cancer Center (Melanoma/NSCLC), Louisville
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/16更新 · NCT06060613A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
- University of Louisville, Louisville
被験者募集中第1/2相
18歳〜70歳 · 全性別 · 2026/06/11更新 · NCT05361174MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
- University of Kentucky, Lexington
被験者募集中第1/2相
18歳〜90歳 · 全性別 · 2026/06/10更新 · NCT05655312Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Flaget Memorial Hospital, Bardstown
- Saint Joseph Hospital East, Lexington
- Saint Joseph London, London
- 他2件
被験者募集中観察研究
18歳以上 · 全性別 · 2026/03/17更新 · NCT06418204Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
- St Elizabeth Healthcare (St Elizabeth Medical Center), Edgewood
- St Elizabeth Healthcare (St Elizabeth Medical, Edgewood
被験者募集中第3相
18歳以上 · 全性別 · 2026/02/25更新 · NCT05549297Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma
- Markey Cancer Center, Lexington
被験者募集中第1相
18歳以上 · 全性別 · 2026/02/13更新 · NCT04903119A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 115, Louisville
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/11/21更新 · NCT05914116Beta Glucan's Effect on Pembrolizumab Immunologic Response in Stage III-IV Melanoma
- University of Louisville, Louisville
被験者募集中
18歳以上 · 全性別 · 2025/10/30更新 · NCT04513028Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
- University of Kentucky, Lexington
被験者募集中
18歳以上 · 全性別 · 2024/11/27更新 · NCT03860883Neoadjuvant Combination Immunotherapy for Stage III Melanoma
- University of Louisville, Louisville
被験者募集中第2相
18歳以上 · 全性別 · 2024/05/02更新 · NCT03842943The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors
- Baptist Health Clinical Research, Elizabethtown
被験者募集中観察研究
18歳以上 · 全性別 · 2022/04/27更新 · NCT05037825A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- James Graham Brown Cancer Center-University of Louisville, Louisville
被験者募集中第1/2相
18歳以上 · 全性別 · 2021/10/29更新 · NCT01638676ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。